科拓生物(300858) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was ¥77,015,201.53, a decrease of 28.19% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥31,672,989.50, down 24.29% year-on-year[5]. - The basic earnings per share for Q3 2023 was ¥0.12, reflecting a decline of 36.84% compared to the previous year[5]. - The company's total revenue for the current period is CNY 216,946,877.08, a decrease of approximately 18% compared to CNY 264,098,724.86 in the previous period[26]. - The net profit for Q3 2023 was CNY 72,005,586.17, a decrease of 17% compared to CNY 86,657,083.83 in Q3 2022[28]. - Operating profit for Q3 2023 was CNY 79,170,447.04, down 21% from CNY 99,795,041.38 in Q3 2022[28]. - The company’s total profit for Q3 2023 was CNY 78,776,543.27, a decrease of 20% from CNY 98,748,330.74 in Q3 2022[28]. - Basic and diluted earnings per share for Q3 2023 were both CNY 0.27, down from CNY 0.39 in Q3 2022[28]. Assets and Liabilities - Total assets at the end of Q3 2023 amounted to ¥1,782,902,640.72, a slight decrease of 0.43% from the end of the previous year[5]. - The total assets as of September 30, 2023, are CNY 1,782,902,640.72, slightly down from CNY 1,791,677,850.18 at the beginning of the year[24]. - The total liabilities decreased from CNY 95,109,880.36 to CNY 71,375,835.75, indicating a reduction of approximately 25%[24]. - The company's cash and cash equivalents decreased from CNY 875,358,498.68 to CNY 349,156,135.27, a decline of about 60%[22]. - The inventory level as of September 30, 2023, is CNY 47,745,665.25, down from CNY 50,933,233.63, reflecting a decrease of approximately 6%[23]. - The company's non-current assets increased from CNY 464,691,808.86 to CNY 678,469,241.05, representing a growth of about 46%[24]. - The company's retained earnings increased from CNY 284,093,672.49 to CNY 303,400,235.05, showing an increase of approximately 7%[24]. Cash Flow - Cash flow from operating activities for the first nine months of 2023 was ¥81,284,368.67, down 20.07% year-on-year[5]. - Cash flow from operating activities generated a net amount of CNY 81,284,368.67, a decrease of 20% compared to CNY 101,696,546.56 in Q3 2022[30]. - The company experienced a cash outflow from investing activities of CNY 553,783,457.47, worsening from a cash outflow of CNY 371,755,929.56 in the previous year[30]. Research and Development - Research and development expenses for the first nine months of 2023 increased by 46.14% to ¥24,693,697.74, driven by higher project investments[10]. - Research and development expenses increased to CNY 24,693,697.74, up 46% from CNY 16,897,008.90 in the same period last year[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,294[12]. - The largest shareholder, Sun Tiansong, holds 26.33% of the shares, totaling 69,383,312 shares[12]. - Beijing Kerongda Investment Partnership holds 10.23% of the shares, totaling 26,960,866 shares[12]. - The total number of restricted shares for Sun Tiansong at the beginning of the period was 44,918,642, with 16,844,492 shares released during the period[15]. - The total number of unrestricted shares held by the top ten shareholders includes 26,960,866 shares from Beijing Kerongda Investment Partnership and 16,844,492 shares from Sun Tiansong[13]. - The total number of shares held by Zhang Liebing is 13,030,513, representing 4.95% of the total shares[12]. - The total number of shares held by Qiao Xiangqian is 11,888,100, representing 4.51% of the total shares[12]. - The total number of shares held by Beijing Kehui Investment Partnership is 11,655,768, representing 4.42% of the total shares[12]. - Liu Xiaojun holds 4.37% of the shares, totaling 11,510,495 shares[13]. - The total number of shares held by Huaxin New Industry Mixed Securities Investment Fund is 9,599,413, representing 3.64% of the total shares[13]. Financial Expenses and Income - The company reported a significant increase in other current assets, which rose by 15,846.20% to ¥510,561,609.58 due to the purchase of time deposits[9]. - The company experienced a 57.77% increase in taxes and surcharges, totaling ¥3,173,889.38, primarily due to higher land use tax payments[10]. - The company’s financial expenses for the first nine months of 2023 showed a dramatic increase of 565.60%, amounting to -¥16,698,531.50, attributed to increased time deposit purchases[10]. - The company’s cash received from government subsidies increased by 73.51% to ¥14,386,550.09 in the first nine months of 2023[10]. - The company reported a significant increase in financial income, with interest income rising to CNY 17,103,724.52 from CNY 2,851,331.02 in the previous year[28].